| Erlotinib Versus Gemcitabine Plus Cisplatin as Neoadjuvant Treatment of Stage IIIA-N2 EGFR-Mutant Non–Small-Cell Lung Cancer (EMERGING-CTONG 1103): A … WZ Zhong, KN Chen, C Chen, CD Gu, J Wang, XN Yang, WM Mao, ... Journal of clinical oncology 37 (25), 2235-2245, 2019 | 250 | 2019 |
| High-level expression of Rad51 is an independent prognostic marker of survival in non-small-cell lung cancer patients GB Qiao, YL Wu, XN Yang, WZ Zhong, D Xie, XY Guan, D Fischer, ... British journal of cancer 93 (1), 137-143, 2005 | 220 | 2005 |
| Serologic association between human papillomavirus type 16 infection and esophageal cancer in Shaanxi Province, China C Han, G Qiao, NL Hubbert, L Li, C Sun, Y Wang, M Yan, D Xu, Y Li, ... JNCI: Journal of the National Cancer Institute 88 (20), 1467-1471, 1996 | 97 | 1996 |
| Biomarkers for early diagnosis, prognosis, prediction, and recurrence monitoring of non-small cell lung cancer Y Tang, G Qiao, E Xu, Y Xuan, M Liao, G Yin OncoTargets and therapy, 4527-4534, 2017 | 87 | 2017 |
| Modified rehabilitation exercises for mild cases of COVID-19 L Zha, X Xu, D Wang, G Qiao, W Zhuang, S Huang Annals of palliative medicine 9 (5), 3100106-3103106, 2020 | 76 | 2020 |
| Expert consensus on neoadjuvant immunotherapy for non-small cell lung cancer W Liang, K Cai, C Chen, H Chen, Q Chen, J Fu, J Hu, T Jiang, W Jiao, ... Translational lung cancer research 9 (6), 2696, 2020 | 73 | 2020 |
| The Society for Translational Medicine: clinical practice guidelines for the postoperative management of chest tube for patients undergoing lobectomy S Gao, Z Zhang, J Aragón, A Brunelli, S Cassivi, Y Chai, C Chen, C Chen, ... Journal of thoracic disease 9 (9), 3255, 2017 | 62 | 2017 |
| Long noncoding RNA CASC9. 5 promotes the proliferation and metastasis of lung adenocarcinoma J Zhou, H Xiao, X Yang, H Tian, Z Xu, Y Zhong, L Ma, W Zhang, G Qiao, ... Scientific reports 8 (1), 37, 2018 | 61 | 2018 |
| Erlotinib versus gemcitabine plus cisplatin as neoadjuvant treatment of stage IIIA-N2 EGFR-mutant non-small-cell lung cancer: final overall survival analysis of the … WZ Zhong, HH Yan, KN Chen, C Chen, CD Gu, J Wang, XN Yang, ... Signal transduction and targeted therapy 8 (1), 76, 2023 | 37 | 2023 |
| Development and validation of a preoperative CT-based radiomic nomogram to predict pathology invasiveness in patients with a solitary pulmonary nodule: a machine learning … L Huang, W Lin, D Xie, Y Yu, H Cao, G Liao, S Wu, L Yao, Z Wang, ... European Radiology, 1-14, 2022 | 37 | 2022 |
| Co‐overexpression of fibroblast growth factor 3 and epidermal growth factor receptor is correlated with the development of nonsmall cell lung carcinoma ALS Tai, JST Sham, D Xie, Y Fang, YL Wu, L Hu, W Deng, GSW Tsao, ... Cancer 106 (1), 146-155, 2006 | 34 | 2006 |
| Society for Translational Medicine consensus on postoperative management of EGFR-mutant lung cancer (2019 edition) W Liang, K Cai, C Chen, H Chen, W Fang, J Fu, X Fu, S Gao, J Hu, ... Translational lung cancer research 8 (6), 1163, 2019 | 32 | 2019 |
| Discovery and validation of methylation signatures in circulating cell-free DNA for early detection of esophageal cancer: a case-control study G Qiao, W Zhuang, B Dong, C Li, J Xu, G Wang, L Xie, Z Zhou, D Tian, ... BMC medicine 19, 1-13, 2021 | 30 | 2021 |
| TCF19 contributes to cell proliferation of non‐small cell lung cancer by inhibiting FOXO1 ZH Zhou, G Chen, C Deng, JM Tang, L Xie, HY Zhou, X Ye, DK Zhang, ... Cell Biology International 43 (12), 1416-1424, 2019 | 30 | 2019 |
| MDM2 promotes epithelial–mesenchymal transition through activation of Smad2/3 signaling pathway in lung adenocarcinoma Y Tang, Y Xuan, G Qiao, Z Ou, Z He, Q Zhu, M Liao, G Yin OncoTargets and therapy, 2247-2258, 2019 | 26 | 2019 |
| Overexpression of P53 and its risk factors in esophageal cancer in urban areas of Xi’an GB Qiao, CL Han, RC Jiang, CS Sun, Y Wang, YJ Wang World Journal of Gastroenterology 4 (1), 57, 1998 | 25 | 1998 |
| The Society for Translational Medicine: clinical practice guidelines for mechanical ventilation management for patients undergoing lobectomy S Gao, Z Zhang, A Brunelli, C Chen, C Chen, G Chen, H Chen, JS Chen, ... Journal of Thoracic Disease 9 (9), 3246, 2017 | 24 | 2017 |
| CTONG1103: Final overall survival analysis of the randomized phase 2 trial of erlotinib versus gemcitabine plus cisplatin as neoadjuvant treatment of stage IIIA-N2 EGFR-mutant … YL Wu, W Zhong, KN Chen, C Chen, F Yang, XN Yang, C Gu, W Mao, ... Journal of Clinical Oncology 39 (15_suppl), 8502-8502, 2021 | 20 | 2021 |
| Clinical features of bronchioloalveolar carcinoma with new histologic and staging definitions JO Ebbert, L Chhatwani, MC Aubry, J Wampfler, S Stoddard, F Zhang, ... Journal of Thoracic Oncology 5 (8), 1213-1220, 2010 | 20 | 2010 |
| Multiple-bar Nuss operation: an individualized treatment scheme for patients with significantly asymmetric pectus excavatum XS Ben, C Deng, D Tian, JM Tang, L Xie, X Ye, ZH Zhou, HY Zhou, ... Journal of Thoracic Disease 12 (3), 949, 2020 | 19 | 2020 |
